In a study by Barnum and colleagues, levels of complement proteins C1q, C3b, C4d, C3aR, and C5aR, and FBb were upregulated in MS brains and spinal cords compared with controls, suggesting involvement of classical and alternative complement pathways [266]. The gene discussed is C3; the disease is myeloid sarcoma.